Peter Weinstein, Ph.D., J.D.

Dr. Peter Weinstein is an accomplished biotech executive, registered patent attorney, and co-founder. Peter brings over 35 years of experience in immunology, intellectual property, and business leadership. As CEO and Board Member, he guides Circurna’s strategy, leads a robust IP pipeline, and guides multidisciplinary teams from innovation to commercialization. Previously, Peter managed global IP portfolios […]

Robert Rickert, Ph.D.

Visionary immunologist and oncology R&D leader with over 25 years of experience in both academia and industry. As a former Chief Scientific Officer and SVP at Pfizer, Robert led global immuno-oncology discovery efforts. He has advanced more than a dozen Immunotherapeutics to the clinic, including CAR-T, bi-specifics, and innovative cytokine therapies. He possesses deep expertise […]

Andre Ghetti, Ph.D.

Dr. Andre Ghetti is a biotech innovator and translational research leader with deep expertise in molecular biology, neuroscience, and drug discovery. As CEO of AnaBios Corporation and former President of Aviva Biosciences, he has built and commercialized cutting-edge human cell-based platforms for pharmaceutical R&D. Andre’s scientific leadership spans senior roles at Vertex Pharmaceuticals and the […]